Why Mycronic stock moves
Mycronic rose slightly despite company news.
Written after the close on ·
Why today
15,984 news analyzed todayMycronic rose slightly despite company news.
Over the same day the market fell clearly, so the stock moved against it.
The company raised its earnings forecasts after a strong report, but its target price was lowered.
It also won a mask writer order from a new Asian customer, worth USD 4-5 million.
Over the last five trading days the stock fell sharply while the market was roughly flat.
Today's move of +1.23% was 0.9 times a normal day's 1.4%. OMX Stockholm 30 moved −1.01% on the same day.
Mycronic +1.23%OMX Stockholm 30 −1.01%Against the market
What analysts expect, and how often they have been right
Analysts’ estimates for Mycronic.
Mycronic earned more than expected in 4 out of 8 reports.
Not in the chart because no estimate and result are available: 3 of the 11 reports in this period, the latest on February 6, 2025.
For comparison, about 46% of reports from Nordic companies beat the estimate in the last three years.
The share moved in the same direction as the earnings surprise in 6 out of 8 reports with a measured move, against about 63% of reports from Nordic companies.
Ratings
Price targets
Latest price 278.80 SEK
Earnings against expectations, and the share’s reaction
Expected EPSAbove estimateBelow estimateAs expectedSEK
Next reported quarter: expected earnings per share of 1.62 SEK (February 4). For the current fiscal year, expected earnings per share changed from 10.22 SEK three months ago to 11.11 SEK now. 2026 estimate: 11.11 SEK. 2027 estimate: 11.49 SEK. One analyst made the estimate for the quarter. People on the board and in management must report their trades in the share to Finansinspektionen, Sweden's financial supervisor. May 25: Sell about 6.2 m SEK. May 22: Sell about 15 m SEK.
Has the share price followed the business?
Price and earnings moved in the same direction: 2 out of 3 years. Across Nordic companies, that happens in about 60% of years. In 2025, the price changed +12% and earnings per share −7%.
Revenue, profit and market cap
RevenueProfitMarket capHatched bars: analysts’ estimates.bn SEK
Assets, liabilities and market cap
AssetsLiabilitiesMarket capbn SEK
Price and earnings moved in the same direction: 2 out of 3 years.Market cap (Now): 54.4 bn SEKRevenue 2025: 7.9 bn SEK
What the key figures say about Mycronic
The figures connect what Mycronic earns with what investors pay.
The line shows the share price in the same year, on its own scale. Hatched bars: analysts’ estimates.
Profit divided by the number of shares. Each share represents this much of the earnings.
2022–2025: 3.79 SEK–8.62 SEK. Peers: Trelleborg 17.67 SEK, Beijer Alma 13.70 SEK, Wärtsilä 1.10 EUR. 2026 estimate: 11.11 SEK (10.40 SEK–11.44 SEK). 2027 estimate: 11.49 SEK (10.70 SEK–12.61 SEK).
What the company sold during the year.
2022–2025: 5.1 bn SEK–7.9 bn SEK. Peers: Trelleborg 35.4 bn SEK, Beijer Alma 8.1 bn SEK, Wärtsilä 7.0 bn EUR. 2026 estimate: 9.7 bn SEK (9.7 bn SEK–9.8 bn SEK). 2027 estimate: 10.4 bn SEK (9.8 bn SEK–10.8 bn SEK).
The percentage of revenue left after the costs of running the business.
2022–2025: 17.5%–28.5%. Peers: Trelleborg 17.2%, Beijer Alma 14.8%, Wärtsilä 12.6%.
Profit as a percentage of shareholders’ money in the company.
2022–2025: 15.9%–25.8%. Peers: Beijer Alma 17.5%, Wärtsilä 24.7%.
The price investors pay for each unit of annual earnings per share. Not shown for a loss.
2022–2025: 23.2–28.1. Peers: Trelleborg 25.7, Beijer Alma 22.0, Wärtsilä 23.5. 2026 estimate: 25.1. 2027 estimate: 24.3.
What investors pay for each unit the company sells.
2022–2025: 3.74–5.52. Peers: Trelleborg 2.84, Beijer Alma 2.23, Wärtsilä 2.18. 2026 estimate: 5.59. 2027 estimate: 5.25.
Money paid to shareholders per share, summed by calendar year.
2017–2025: 1.00 SEK–3.75 SEK.
The ordinary yearly dividend as a percentage of the share price.
2022–2025: 1.1%–1.7%. Peers: Trelleborg 1.8%, Beijer Alma 1.3%, Wärtsilä 2.1%.
Net debt divided by operating earnings before depreciation and amortisation.
2022–2025: -1.24–-0.85. Peers: Trelleborg 1.24, Beijer Alma 1.93, Wärtsilä -2.15.
More key figures
Market cap divided by shareholders’ equity, what remains after liabilities.
2022–2025: 4.10–6.13. Peers: Trelleborg 2.70, Beijer Alma 3.61, Wärtsilä 5.74.
Market cap plus net debt, divided by operating earnings. This includes debt.
2022–2025: 17.2–20.9.
Cash left after investments, divided by the number of shares.
2022–2025: 3.64 SEK–8.38 SEK. Peers: Beijer Alma 14.75 SEK, Wärtsilä 2.65 EUR.
The percentage of assets financed by shareholders’ equity.
2022–2025: 62.7%–65.1%.
The dividend explained
A dividend is money paid to shareholders. Mycronic paid 3.25 SEK per share in the twelve months through November 6, 2026.
On the ex-dividend day, May 7, 2026, Mycronic traded without the right to the 3.25 SEK dividend. The price went from 298.60 SEK to 292.60 SEK; including the dividend, the day's change was −0.9%. Entitlement passes from the company to shareholders on the ex-day; payment comes later.
2017: 1.00 SEK2018: 1.25 SEK2019: 1.50 SEK2020: 1.00 SEK2021: 1.50 SEK2022: 1.50 SEK2023: 1.75 SEK2024: 2.25 SEK2025: 3.75 SEK2026 so far: 3.25 SEK
What followed similar falls?
Including reinvested dividends, Mycronic fell 7.4% over the latest five trading days. Since November 7, 2016, falls at least this large were followed by a higher value 21 trading days later in 24 out of 39 non-overlapping periods. The median was +2.0%, against +1.4% for an ordinary 21-day period, which ended higher 56 times in 100.
Such a fall has not said much about the next month.
+2.0% · 24/39
What to watch next, and why
The earnings report shows how Mycronic's revenue and profit have changed.
- Earnings report
The earnings report shows how Mycronic's revenue and profit have changed.
Add to calendar
More about Mycronic
Insider trades
People on the board and in management must report their trades in the share to Finansinspektionen, Sweden's financial supervisor.
- Patrik Tigerschiöld, chairSellabout 6.2 m SEK
- Patrik Tigerschiöld, chairSellabout 15 m SEK
Earnings report
Next report: · Add to calendar · Google Calendar
On its last 15 report days Mycronic usually moved about 5.9%. On a normal day it moves 1.4%.
+2.59% +15.30% +12.03% −9.56%
10,000 SEK in Mycronic bought on November 7, 2016 is worth 71,500 SEK today, with dividends reinvested.
What would 10,000 SEK in Mycronic be worth today? →
What would 10,000 SEK in Mycronic be worth today?
71,500 SEK
with dividends reinvested, bought on November 7, 2016.
At worst it was worth 7,920 SEK (August 29, 2017).
The five biggest days of the journey
· +28.1% · the whole market rose 0.9% the same day · report day
· +17.3% · the whole market fell 0.3% the same day
· −16.9% · the whole market rose 1.4% the same day · report day
· +15.3% · the whole market fell 0.1% the same day · report day
· +13.4% · the whole market rose 2.6% the same day
Earlier days
−7.38% market −0.11% Mycronic fell sharply over the week, while the broader Stockholm market was roughly flat. Read →
Mycronic fell sharply over the week, while the broader Stockholm market was roughly flat.
The drop was a big move for the company, rare in the past year.
Likely drivers: a raised earnings forecast from the company after a strong report, but with the target price, the share price analysts see as fair, lowered, which weighed on the shares.
Partly offsetting this, Mycronic won a new order worth USD 4–5 million for its SLX mask writer, a machine that makes photomasks used in chipmaking, with delivery planned for early 2027.
−3.50% market −0.32% Mycronic fell sharply as the market slipped slightly. Read →
Mycronic fell sharply as the market slipped slightly.
The stock fell hard over the last five trading days while OMX Stockholm 30 rose slightly, so it moved against the market.
The move was very big for Mycronic, and short positions rose sharply over the same days.
Next up is the earnings report on Thursday 4 February 2027.
−3.45% market +0.83% Mycronic fell sharply, without company news. Read →
Mycronic fell sharply, without company news.
Mycronic fell, while the OMX Stockholm 30 rose clearly, so it moved against the market.
No company news from that session explains the move.
Over the last five trading days, Mycronic fell sharply, which is a big move for the stock, roughly three times a normal five-day stretch.
The stock trades well below its highest close of the past year.
−3.65% market −0.29% Mycronic fell sharply, with no clear company news. Read →
Mycronic fell sharply, with no clear company news.
Mycronic fell much more than the market in the last session, while OMX Stockholm 30 slipped slightly.
No company news from that session explains the drop.
Over the last five trading days the stock rose slightly, while the market rose clearly.
+1.62% market +3.01% Mycronic rose slightly over the week's trading days, moving less than the broader market, which rose clearly. Read →
Mycronic rose slightly over the week's trading days, moving less than the broader market, which rose clearly.
The last session saw a sharp fall, more than the market's slight decline.
Company news included new orders for its mask writers, machines that make the photomasks used in chipmaking.
Analysts including ABG Sundal Collier and JPMorgan were also active.
Learn more · Why do stocks go up and down?